645 related articles for article (PubMed ID: 21115357)
21. [Effect of tranexamic acid on postoperative bleeding in pediatric heart surgery].
Varela Crespo CA; Sanabria Carretero P; Palomero Rodríguez MA; Tormo las de Heras C; Rodríguez Pérez E; Goldman Tarlousky L
Rev Esp Anestesiol Reanim; 2007 Mar; 54(3):155-61. PubMed ID: 17436653
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
Andreasen JJ; Nielsen C
Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
[TBL] [Abstract][Full Text] [Related]
23. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion.
Kristeller JL; Stahl RF; Roslund BP; Roke-Thomas M
Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Epsilon amino-caproic acid (EACA) and autologous blood as blood conservation strategies in patients undergoing cardiac surgery.
Sharma V; Talwar S; Choudhary SK; Lakshmy R; Kale S; Kumar AS
Heart Lung Circ; 2006 Aug; 15(4):261-5. PubMed ID: 16698318
[TBL] [Abstract][Full Text] [Related]
25. Epsilon-aminocaproic acid versus tranexamic acid in total knee arthroplasty: a meta-analysis study.
Riaz O; Aqil A; Asmar S; Vanker R; Hahnel J; Brew C; Grogan R; Radcliffe G
J Orthop Traumatol; 2019 Jul; 20(1):28. PubMed ID: 31321578
[TBL] [Abstract][Full Text] [Related]
26. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.
Lu J; Meng H; Meng Z; Sun Y; Pribis JP; Zhu C; Li Q
Int J Clin Exp Pathol; 2015; 8(7):7978-87. PubMed ID: 26339364
[TBL] [Abstract][Full Text] [Related]
27. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients.
Martin K; Wiesner G; Breuer T; Lange R; Tassani P
Anesth Analg; 2008 Dec; 107(6):1783-90. PubMed ID: 19020118
[TBL] [Abstract][Full Text] [Related]
28. Blood Conservation Using Tranexamic Acid Is Not Superior to Epsilon-Aminocaproic Acid After Total Knee Arthroplasty.
Boese CK; Centeno L; Walters RW
J Bone Joint Surg Am; 2017 Oct; 99(19):1621-1628. PubMed ID: 28976426
[TBL] [Abstract][Full Text] [Related]
29. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
[TBL] [Abstract][Full Text] [Related]
30. Aprotinin in cardiac surgery patients: is the risk worth the benefit?
Stamou SC; Reames MK; Skipper E; Stiegel RM; Nussbaum M; Geller R; Robicsek F; Lobdell KW
Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574
[TBL] [Abstract][Full Text] [Related]
31. Effect of topical tranexamic acid in open heart surgery.
Abul-Azm A; Abdullah KM
Eur J Anaesthesiol; 2006 May; 23(5):380-4. PubMed ID: 16438759
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial.
Goobie SM; Meier PM; Pereira LM; McGowan FX; Prescilla RP; Scharp LA; Rogers GF; Proctor MR; Meara JG; Soriano SG; Zurakowski D; Sethna NF
Anesthesiology; 2011 Apr; 114(4):862-71. PubMed ID: 21364458
[TBL] [Abstract][Full Text] [Related]
33. A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).
Bokesch PM; Szabo G; Wojdyga R; Grocott HP; Smith PK; Mazer CD; Vetticaden S; Wheeler A; Levy JH
J Thorac Cardiovasc Surg; 2012 May; 143(5):1022-9. PubMed ID: 21724197
[TBL] [Abstract][Full Text] [Related]
34. Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety.
Sarupria A; Makhija N; Lakshmy R; Kiran U
J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):23-9. PubMed ID: 22995453
[TBL] [Abstract][Full Text] [Related]
35. Tranexamic Acid in cardiac surgery and postoperative seizures: a case report series.
Bell D; Marasco S; Almeida A; Rowland M
Heart Surg Forum; 2010 Aug; 13(4):E257-9. PubMed ID: 20719731
[TBL] [Abstract][Full Text] [Related]
36. The risks associated with aprotinin use: a retrospective study of cardiac cases in Nova Scotia.
Riddell RE; Buth KJ; Sullivan JA
Can J Anaesth; 2013 Jan; 60(1):16-23. PubMed ID: 23132043
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of tranexamic acid versus ϵ-aminocaproic acid in cardiovascular surgery.
Falana O; Patel G
Ann Pharmacother; 2014 Dec; 48(12):1563-9. PubMed ID: 25214649
[TBL] [Abstract][Full Text] [Related]
38. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis.
Shapiro F; Zurakowski D; Sethna NF
Spine (Phila Pa 1976); 2007 Sep; 32(20):2278-83. PubMed ID: 17873823
[TBL] [Abstract][Full Text] [Related]
39. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Fergusson DA; Hébert PC; Mazer CD; Fremes S; MacAdams C; Murkin JM; Teoh K; Duke PC; Arellano R; Blajchman MA; Bussières JS; Côté D; Karski J; Martineau R; Robblee JA; Rodger M; Wells G; Clinch J; Pretorius R;
N Engl J Med; 2008 May; 358(22):2319-31. PubMed ID: 18480196
[TBL] [Abstract][Full Text] [Related]
40. Intraoperative tranexamic acid reduces blood transfusion in children undergoing craniosynostosis surgery: a randomized double-blind study.
Dadure C; Sauter M; Bringuier S; Bigorre M; Raux O; Rochette A; Canaud N; Capdevila X
Anesthesiology; 2011 Apr; 114(4):856-61. PubMed ID: 21358317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
